Keywords: GlaxoSmithKline, Theravance, Respiratory, Relovair, Equity stake

GlaxoSmithKline ups stake in Theravance to 19%, buying additional shares for $129.4 million

Article | 30 November 2010

UK pharmaceutical giant GlaxoSmithKline (LSE: GSK) revealed yesterday that it will increase its shareholding in US respiratory drug partner Theravance ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GlaxoSmithKline

Theravance

Go to company listing

Related Drugs

Relovair

Go to drug listing